The annual morbidity and mortality rate in dialysis patients remains high despite the marked improvement in dialysis technology and patient care. Many hemodialysis (HD) patients 1-4 show increase in IL 6, which is indicated by increased circulating levels of nonspecific markers of inflammation. IL-6 plays an important role in inflammation, being the most potent inducer of the acute-phase response. 5 Nutritional status is important to analysis the CKD patients for morbidity and mortality 6,7 as well as in their quality of life and ultimate rehabilitative potential.